The proportion of MRSA isolates declined significantly from 2010 through 2019, but resistance to non–beta-lactam antibiotics rose, particularly in southern states.
The intervention involved use of an antiseptic soap and nasal ointment on patients in a network of hospitals, nursing homes, and long-term care facilities.
Data collected from 29 European countries revealed interactions between age, sex, and resistant bloodstream infections.
Data on Salmonella and Campylobacter bacteria from people and food-producing animals show high levels of resistance to commonly used antibiotics.
A review of randomized controlled trials found that Asian and Black participants were underrepresented.
The study highlights the impact of community COVID-19 incidence on racial disparities in invasive Staphylococcus aureus infections.
The studies examined trends in hospitalized patients, and the authors said the findings support the need for better infection-prevention strategies in the region.
A trial found that mupirocin was more effective than iodophore in reducing Staphylococcus aureus in ICU patients.
A phase 3 trial shows ceftobiprole was noninferior to daptomycin in patients with complicated Staphylococcus aureus bacteremia.
The grant focuses on infections caused by Staphylococcus, including MRSA, and Candida, an invasive fungus that is often drug-resistant.
